CN107981344B - 一种具有通便功能的香蕉冻干粉组合物及其制备方法 - Google Patents
一种具有通便功能的香蕉冻干粉组合物及其制备方法 Download PDFInfo
- Publication number
- CN107981344B CN107981344B CN201810050946.7A CN201810050946A CN107981344B CN 107981344 B CN107981344 B CN 107981344B CN 201810050946 A CN201810050946 A CN 201810050946A CN 107981344 B CN107981344 B CN 107981344B
- Authority
- CN
- China
- Prior art keywords
- banana
- freeze
- dried powder
- parts
- powder composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000018290 Musa x paradisiaca Nutrition 0.000 title claims abstract description 102
- 239000000203 mixture Substances 0.000 title claims abstract description 79
- 239000000843 powder Substances 0.000 title claims abstract description 77
- 230000002040 relaxant effect Effects 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 241000234295 Musa Species 0.000 title claims abstract 24
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims abstract description 35
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract description 33
- 229960004488 linolenic acid Drugs 0.000 claims abstract description 33
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims abstract description 31
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 30
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 24
- 239000002131 composite material Substances 0.000 claims abstract description 22
- 229920001202 Inulin Polymers 0.000 claims abstract description 16
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 16
- 229940029339 inulin Drugs 0.000 claims abstract description 16
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 15
- 206010010774 Constipation Diseases 0.000 claims abstract description 9
- 235000013311 vegetables Nutrition 0.000 claims abstract description 8
- 239000003921 oil Substances 0.000 claims description 33
- 235000019198 oils Nutrition 0.000 claims description 33
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 30
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 30
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 26
- 241000196324 Embryophyta Species 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 17
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 16
- 235000021015 bananas Nutrition 0.000 claims description 15
- 235000012000 cholesterol Nutrition 0.000 claims description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- 239000000944 linseed oil Substances 0.000 claims description 12
- 235000021388 linseed oil Nutrition 0.000 claims description 12
- 241000208688 Eucommia Species 0.000 claims description 11
- 239000001335 perilla frutescens leaf extract Substances 0.000 claims description 11
- 150000003904 phospholipids Chemical class 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 10
- 239000004475 Arginine Substances 0.000 claims description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 3
- 239000005977 Ethylene Substances 0.000 claims description 3
- HWMVXEKEEAIYGB-UHFFFAOYSA-K Isocitric acid, DL- Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C(O)C(C([O-])=O)CC([O-])=O HWMVXEKEEAIYGB-UHFFFAOYSA-K 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 claims description 2
- 108010012715 Superoxide dismutase Proteins 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 230000003248 secreting effect Effects 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 34
- 210000004369 blood Anatomy 0.000 abstract description 34
- 230000000694 effects Effects 0.000 abstract description 19
- 230000001603 reducing effect Effects 0.000 abstract description 18
- 235000019197 fats Nutrition 0.000 abstract description 15
- 235000019640 taste Nutrition 0.000 abstract description 8
- 239000012535 impurity Substances 0.000 abstract description 6
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 3
- 229930195729 fatty acid Natural products 0.000 abstract description 3
- 239000000194 fatty acid Substances 0.000 abstract description 3
- 150000004665 fatty acids Chemical class 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 description 93
- 230000000052 comparative effect Effects 0.000 description 33
- 241000699670 Mus sp. Species 0.000 description 22
- 238000012360 testing method Methods 0.000 description 19
- 238000000855 fermentation Methods 0.000 description 12
- 230000004151 fermentation Effects 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 9
- 230000013872 defecation Effects 0.000 description 8
- 239000013641 positive control Substances 0.000 description 8
- 230000001953 sensory effect Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- -1 polyene fatty acid Chemical class 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 229960004192 diphenoxylate Drugs 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 229960004329 metformin hydrochloride Drugs 0.000 description 5
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 description 5
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin hydrochloride Natural products CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 210000000813 small intestine Anatomy 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000010779 crude oil Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical class [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000008157 edible vegetable oil Substances 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000001050 lubricating effect Effects 0.000 description 2
- 239000008176 lyophilized powder Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 238000006864 oxidative decomposition reaction Methods 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- JKBKMIKSUBLJRK-UHFFFAOYSA-N 2-propylsulfanylpyrimidine Chemical compound CCCSC1=NC=CC=N1 JKBKMIKSUBLJRK-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000219226 Acer truncatum Species 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 241001464837 Viridiplantae Species 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 238000009874 alkali refining Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000007215 black sesame Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- OKTJSMMVPCPJKN-YPZZEJLDSA-N carbon-10 atom Chemical compound [10C] OKTJSMMVPCPJKN-YPZZEJLDSA-N 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000009384 kangtai Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001141 propulsive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3526—Organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/28—Removal of unwanted matter, e.g. deodorisation or detoxification using microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/41—Retaining or modifying natural colour by use of additives, e.g. optical brighteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于食品技术领域,具体涉及一种具有通便功能的香蕉冻干粉组合物及其制备方法。本发明提供的具有通便功能的香蕉冻干粉组合物包括香蕉发酵冻干粉10~15份、菊粉1~4份、硬脂酸镁0.05~1.2份、乳化剂0.1~0.3份、亚麻酸0.5~1.5份和植物复合油0.4~1.6份。本发明制备的香蕉冻干粉组合物食用方便,口感纯正,具有巧克力风味,无杂质且易于溶解,提供必须脂肪酸的同时,还具有极显著的通便排毒、降糖降脂的功效。
Description
技术领域
本发明属于食品技术领域,具体涉及一种具有通便功能的香蕉冻干粉组合物及其制备方法。
背景技术
香蕉(Musaparadisiaca)是生长在我国南方热带、亚热带的一种重要水果,其营养丰富,味甘性寒,具有较高的药用价值,主要功用是清肠胃,治便秘,并有清热润肺、止烦渴、填精髓、解酒毒等。其中,香蕉富含钾和镁,钾能防止血压上升、肌肉痉挛,镁则具有消除疲劳的效果。香蕉成熟后,所含大量水溶性的植物纤维能引起高渗性的胃肠液分泌,将水分吸附到固体部分,使粪便变软而易排出,从而达到润肠通便的效果。
然而,香蕉作为一种呼吸跃变型水果,容易腐烂,不耐储藏,集中上市期间易滞销,造成大量鲜果腐烂损失,因此香蕉深加工对香蕉产业具有重要的意义。中国专利申请CN102266057A公开了一种具有润肠通便和减轻体重功能的香蕉粉的制作方法,该香蕉粉主要由香蕉全粉与香蕉抗性淀粉以不同比例配合而成,全粉口感香甜,具有润肠通便的功能。该发明把香蕉制备成香蕉粉或组合物的形式不仅可以较好地保持香蕉原有营养成分,食用方便,但其成分简单,营养单一,且在加工过程中果胶和糖类的大量存在,给加工工艺造成困难,同时,因为香蕉含有的较多的芳香物质,极其容易在加工过程中氧化和降解,导致加工产品的香气不明显,需要加入香精导致了产品风味的变化。因此,如何提供一种不易氧化,稳定性优异,且具有通便功能的香蕉粉末成为了目前急需解决的技术问题。
亚麻酸简称LNA,属ω-3系列多烯脂肪酸,以甘油酯的形式存在于深绿色植物中,是构成人体组织细胞的主要成分,在体内转化为机体必需的生命活性因子DHA和EPA,具有预防心脑血管病、降血脂、降低临界性高血压、抑制癌症的发生和转移、抑制过敏反应、抗炎作用、抑制衰老、增强智力等作用,但未公开其在润肠方面的作用。并且,它在人体内不能合成,必须从体外摄取。中国专利申请CN105886103A公开了一种亚麻酸保健食用油、花椒籽粕及其制备方法,包括以下几个步骤:(1)毛油的制取,包括青花椒籽的选材、原料轧胚、毛油浸出;(2)精炼,将步骤(1)制取的毛油进行水化脱胶、碱炼脱酸、水洗除杂、脱水脱色、脱酸脱臭处理,制得的亚麻酸食用油,含棕榈酸8~15%,棕榈油酸5~15%,油酸30~40%,亚油酸20~35%,a-亚麻酸10~18%。该发明亚麻油含量较高,但由于亚麻酸分子中存在三个共轭双键,有非常强的还原性,容易在高温、空气中的氧气、紫外线以及一些重金属离子存在的情况下被氧化,这些特性严重限制了亚麻酸的应用。
亚麻籽油、杜仲籽油和紫苏籽油都含有大量的不饱和脂肪酸和丰富的氨基酸,按一定比例复合制成植物复合油,有亮泽肌肤、改善女性经前综合征、提升抗压力、减轻过敏反应、减轻哮喘、改善关节炎、改善组织发炎、降低胆固醇、降血脂、降低心脏负荷、改善滞水症、促进细胞健康等功能,但未公开其在润肠方面的作用。如中国专利申请CN105886103A公开了一种富含α-亚麻酸保护心血管的调和油,由亚麻籽油、杜仲籽油、牡丹籽油、紫苏籽油、核桃油、番茄籽油、红花籽油、元宝枫籽油、黑芝麻油中的五种或者五种以上调配而成,各种脂肪酸组成比例协调,符合膳食营养指南推荐量。原料油为冷榨经物理精炼获得,不添加任何化学合成抗氧化剂,富含大量保护心脑血管的活性成分,具有显著保护心血管的功能。但该发明以调和油的形式存在,使用时需进行一定的烹饪,在加热时会破坏调和油中的不饱和脂肪酸,营养易流失也不便于人们日常摄入。
针对上述技术问题,有必要提供一种含有香蕉粉末、亚麻酸和植物复合油的具有显著通便功能的组合物,同时该组合物克服了香蕉粉末芳香物质易氧化分解、亚麻酸和植物复合油易氧化的问题。
发明内容
为了解决现有技术中存在的问题,本发明的目的在于提供一种具有通便功能的香蕉冻干粉组合物及其制备方法。
本发明的技术方案是:一种具有通便功能的香蕉冻干粉组合物,包括如下原料及其重量份数:香蕉发酵冻干粉10~15份、菊粉1~4份、硬脂酸镁0.05~1.2份、乳化剂0.1~0.3份、亚麻酸0.5~1.5份和植物复合油0.4~1.6份。
进一步地,所述具有通便功能的香蕉冻干粉组合物,包括如下原料及其重量份数:香蕉发酵冻干粉12.5份、菊粉2.5份、硬脂酸镁0.08份、乳化剂0.15份、亚麻酸1份和植物复合油1份。
更进一步地,所述香蕉发酵冻干粉的制备方法为:
S1、将青香蕉置于含0.05%乙烯的密闭环境中,控制环境温度为25~29℃,采用紫外光照射至香蕉果肉成熟;
S2、将步骤S1所得成熟的香蕉去皮、果肉挤压成浆后加入0.5wt%的异柠檬酸钠,搅拌均匀,35℃时加入1~3wt%的乳酸菌和3~5wt%的重组酵母,发酵3.5~4.5h,得香蕉发酵产物;
S3、向步骤S2所得香蕉发酵产物加入1~3wt%的精氨酸,充分混匀后放入封闭式氮气循环烤箱,设置温度80~90℃,烘干5~7h,得香蕉发酵果肉;
S4、将步骤S3所得香蕉发酵果肉在氮气环境,-18~-22℃条件下冻干后,超微粉碎,即得。
进一步地,步骤S2中所述重组酵母为为中国专利申请CN103333913A所公开的一种可以分泌表达超氧化物歧化酶的工程酿酒酵母。
更进一步地,所述植物复合油由亚麻籽油、杜仲籽油和紫苏籽油按体积比(1~3):(1~3):(1~3)组成。
进一步地,所述乳化剂由胆固醇和磷脂按重量比(1~3):(8~12)组成。
更进一步地,所述乳化剂由胆固醇和磷脂按照1:10的重量比组成。
进一步地,所述具有通便功能的香蕉冻干粉组合物的制备方法,包括以下步骤:
A)将所述香蕉发酵冻干粉、菊粉和硬脂酸镁按相应的重量份数混合,超微粉碎,得粉末Ⅰ;
B)将亚麻酸和植物复合油按相应的重量份数混合均匀,得混合物Ⅱ;
C)将粉末Ⅰ、混合物Ⅱ和乳化剂混合均匀后喷雾干燥,粉碎,过筛,即得。
本发明提供的一种具有通便功能的香蕉冻干粉组合物,在加工过程中添加重组酵母对成熟香蕉进行发酵,一方面消耗了香蕉中的多糖类物质,克服了果胶和糖类大量存在给加工工艺造成的困难,并将多糖类物质转化为SOD及多种生命必需营养素,满足机体需要。另一方面,发明人意外的发现,由于发酵生成的大量SOD的存在,其能显著抑制香蕉中芳香物质的氧化分解,制备得到的香蕉冻干组合物香气浓郁,同时能够显著提高亚麻酸和植物复合油的稳定性。并且,经试验意外地发现,与加入普通酵母发酵及普通酵母发酵后加入SOD相比,加入本发明重组酵母发酵得到的香蕉冻干粉组合物通便和降糖降脂效果都有了显著的提升,且是简单将普通酵母与SOD混合使用所无法替代的。加入精氨酸和发酵残留的还原糖发生美拉德反应,产生宜人可口的巧克力样风味和诱人的色泽,同时美拉德反应中产生的褐变色素、醛、酮等还原性中间产物对油脂类自动氧化表现出抗氧化性,同样也可有效抑制亚麻酸和复合植物油的氧化。此外,菊粉是一类天然果聚糖混合物,具有降低血脂、血糖、促进矿物质的吸收、防便秘、治疗肥胖症的功效,与香蕉共用可显著增加润肠通便的效果,与亚麻酸和复合植物油协同作用,共同促进血糖、血脂的降低。
与现有技术相比,本发明具有以下优点:
(1)本发明香蕉冻干粉便于携带、食用,含有丰富的营养物质,具有显著的润肠通便效果的同时还有降血糖、降血脂的作用;
(2)加入精氨酸与还原糖发生美拉德反应,产生宜人可口的巧克力样风味和诱人的色泽;
(3)本发明香蕉冻干粉组合物能够提供多种益生元,可以建立肠道益生菌群,能够很好地调节人体肠道微生态;
(4)含有大量SOD,减少芳香物质氧化分解,香气浓郁,不需添加香精。
具体实施方式
以下通过实施例形式的具体实施方式,对本发明的上述内容作进一步的详细说明。但不应将此理解为本发明上述主题的范围仅限于以下实施例。
本发明中,亚麻籽油、杜仲籽油和紫苏籽油均购自陕西森弗天然制品有限公司;亚麻酸、精氨酸、胆固醇、磷脂和硬脂酸镁均购自上海源叶生物科技有限公司;乳酸菌购自向日葵生物科技有限公司;酿酒酵母购自上海江莱生物科技有限公司;菊粉购自深圳安泰生物科技有限公司。SOD购自Gentihold货号:S1185。
实施例1、一种具有通便功能的香蕉冻干粉组合物
由如下原料及其重量份数制成:香蕉发酵冻干粉12.5份、菊粉2.5份、硬脂酸镁0.08份、乳化剂0.15份、亚麻酸1份和植物复合油1份,所述植物复合油由亚麻籽油、杜仲籽油和紫苏籽油按体积比1:1:1组成,所述乳化剂由胆固醇和磷脂按照1:10的重量比组成。
制备方法:
(1)香蕉发酵冻干粉的制备
将青香蕉置于含0.05%乙烯的密闭环境中,控制环境温度为25℃,采用紫外光照射至香蕉果肉成熟;所得成熟的香蕉去皮、果肉挤压成浆后加入0.5wt%的异柠檬酸钠,搅拌均匀,35℃时加入2wt%的乳酸菌和4wt%的重组酵母,发酵4h,得香蕉发酵产物;所得香蕉发酵产物加入2.5wt%的精氨酸,充分混匀后放入封闭式氮气循环烤箱,设置温度85℃,烘干6h,得香蕉发酵果肉;所得香蕉发酵果肉在氮气环境,-20℃条件下冻干后,超微粉碎,即得。
(2)香蕉冻干粉组合物的制备
将所述香蕉发酵冻干粉、菊粉和硬脂酸镁按相应的重量份数混合,超微粉碎,得粉末Ⅰ;将亚麻酸和植物复合油按相应的重量份数混合均匀,得混合物Ⅱ;将粉末Ⅰ、混合物Ⅱ和乳化剂混合均匀后喷雾干燥,粉碎,过筛,即得。
实施例2、一种具有通便功能的香蕉冻干粉组合物
由如下原料及其重量份数制成:香蕉发酵冻干粉10份、菊粉3份、硬脂酸镁0.05份、乳化剂0.1份、亚麻酸0.5份和植物复合油0.4份,所述植物复合油由亚麻籽油、杜仲籽油和紫苏籽油按体积比1:2:2组成,所述乳化剂由胆固醇和磷脂按照2:9的重量比组成。
制备方法:参考实施例1。
实施例3、一种具有通便功能的香蕉冻干粉组合物
由如下原料及其重量份数制成:香蕉发酵冻干粉15份、菊粉4份、硬脂酸镁1.2份、乳化剂0.3份、亚麻酸1.5份和植物复合油1.6份,所述植物复合油由亚麻籽油、杜仲籽油和紫苏籽油按体积比2:3:3组成,所述乳化剂由胆固醇和磷脂按照1:12的重量比组成。
制备方法:参考实施例1。
对比例1、一种具有通便功能的香蕉冻干粉组合物
由如下原料及其重量份数制成:香蕉发酵冻干粉12.5份、菊粉2.5份、硬脂酸镁0.08份、乳化剂0.15份、亚麻酸1份和植物复合油1份,所述植物复合油由亚麻籽油、杜仲籽油和紫苏籽油按体积比1:1:1组成,所述乳化剂由胆固醇和磷脂按照1:10的重量比组成。
制备方法:与实施例1的不同在于,将所述转基因SOD酵母换为酿酒酵母,其余参考实施例1。
对比例2、一种具有通便功能的香蕉冻干粉组合物
由如下原料及其重量份数制成:香蕉发酵冻干粉12.5份、菊粉2.5份、硬脂酸镁0.08份、乳化剂0.15份、亚麻酸1份和植物复合油1份,所述植物复合油由亚麻籽油、杜仲籽油和紫苏籽油按体积比1:1:1组成,所述乳化剂由胆固醇和磷脂按照1:10的重量比组成。
制备方法:与实施例1的不同在于,将所述转基因SOD酵母换为酿酒酵母,所得成品加入200U/g的SOD,其余参考实施例1。
对比例3、一种具有通便功能的香蕉冻干粉组合物
由如下原料及其重量份数制成:香蕉发酵冻干粉12.5份、菊粉2.5份、硬脂酸镁0.08份、乳化剂0.15份和植物复合油1份,所述植物复合油由亚麻籽油、杜仲籽油和紫苏籽油按体积比1:1:1组成,所述乳化剂由胆固醇和磷脂按照1:10的重量比组成。
制备方法:与实施例1的不同在于,不添加亚麻酸,其余参考实施例1。
试验例一、感官评价
1.试验材料:实施例1~3及对比例1~3制备的香蕉冻干粉组合物。
2.试验对象:25名健康成年人。
3.试验方法:
让25名健康成年人分别对实施例1~3和对比例1~3制得的香蕉冻干粉组合物的色泽、外观、杂质、冲调性、气味和口感进行感官评价,并按表1感官评价标准进行评价打分。
色泽、外观、杂质的检测方法为:将样品倒在白色搪瓷盘中,在自然光下用肉眼观察;冲调性、气味和口感的检测方法为:取20g样品加入到200mL 85℃水中冲调,玻璃杯搅拌60s后观察溶解情况并品尝。
表1感官评价标准
4.试验结果:测试结果见表2。
表2感官评价结果
类别 | 色泽 | 外观 | 杂质 | 冲调性 | 香气 | 口感 | 总分 |
实施例1 | 4.9 | 4.9 | 5.0 | 4.9 | 5.0 | 5.0 | 29.7 |
实施例2 | 4.7 | 4.6 | 4.8 | 4.7 | 4.7 | 4.8 | 28.3 |
实施例3 | 4.9 | 4.8 | 4.8 | 4.8 | 4.8 | 4.8 | 28.9 |
对比例1 | 2.4 | 2.5 | 3.2 | 3.5 | 2.0 | 2.2 | 15.8 |
对比例2 | 2.6 | 2.8 | 3.5 | 3.6 | 2.6 | 2.5 | 17.6 |
对比例3 | 3.8 | 4.0 | 4.6 | 4.3 | 4.0 | 3.8 | 24.5 |
由表2可知,本发明实施例1~3制备的香蕉冻干粉组合物的感观评价各方面都较好,其中实施例1的评价最好,口感纯正,无杂质且易于溶解,为本发明的最佳实施例。而对比例1~3制备的香蕉冻干粉组合物的感观评价与实施例1~3有显著的差距,其中对比例1(普通酵母发酵)和对比例2(普通酵母发酵+SOD)各方面评分相近且都较低,特别是色泽、外观、香气和口感,说明重组SOD酵母可以有效提高香蕉冻干粉组合物这4个方面的感官特性,且其作用不是简单将酿酒酵母与SOD混合加入能替代的。
试验例二、润肠通便试验
1.试验材料:实施例1~3和对比例1~3制备的香蕉冻干粉组合物。
2.试验对象:健康雄性KM小鼠180只,体重20±2g。
3.试验方法:
3.1小鼠肠推进作用
(1)分组及给药:抽取90只小鼠,随机等分为9组,分别为空白对照组、便秘模型组(复方地芬诺酯:河源市康泰制药厂)、阳性对照组(绿瘦纤姿饮青香蕉固体饮料)、实施例1~3组和对比例1~3组。其中实施例1~3组和对比例1~3组分别灌服实施例1~3和对比例1~3制备的香蕉冻干粉组合物冲调的水溶液5mL(0.03g/mL),阳性对照组灌服绿瘦纤姿饮青香蕉固体饮料冲调的水溶液5mL(0.03g/mL),空白对照组和复方地芬诺酯便秘模型组给予等量的蒸馏水,每天一次,试验期间正常进食,连续喂养7天。
(2)造模:末次给药的当天晚上各组动物禁食(期间自由饮水),16小时后,除空白对照组给予同等体积的蒸馏水外,其余各组均灌胃给予复方地芬诺酯(5mg/kg体重),给予复方地芬诺酯30分钟后,各组分别给予含相应受试药物的墨汁(含5%的活性炭粉、10%阿拉伯树胶),空白对照组和模型对照组给同体积的墨汁灌胃。
(3)小肠推进率实验:墨汁灌胃25分钟后,将上述8组小鼠立即脱颈椎处死,打开腹腔分离肠系膜,剪取上端自幽门、下端至回盲部的肠管,置于托盘上,轻轻将小肠拉成直线,测量肠管长度为“小肠总长度”,从幽门至墨汁前沿为“墨汁推进长度”。按下式计算墨汁推进率:碳墨推进率=墨汁推进长度(cm)/小肠总长度(cm)×100%。
3.2小鼠排便情况
另取90只小鼠,随机等分为9组,按3.1中方法进行分组、给药,从给墨汁开始观察并记录小鼠首粒黑便的排出时间,给药后将小鼠置于铺有滤纸的观察笼中观察6h,并记录各小鼠在6h内所排粪便粒数及重量。
4.试验结果:小鼠肠推进作用及排便情况测试结果见表3和表4。
表3润肠通便测定结果
注:与空白对照组比较,#P<0.05,##P<0.01;与模型组比较,*P<0.05,**P<0.01。
表4小鼠排便情况影响情况
组别 | 例数 | 粪便粒数/n | 排便时间/min | 粪便重量/g |
空白对照组 | 10 | 35.7±6.6 | 45.22±4.53 | 0.405±0.010 |
模型组 | 10 | 19.5±4.6<sup>##</sup> | 79.08±10.52<sup>##</sup> | 0.153±0.015<sup>##</sup> |
阳性对照组 | 10 | 29.7±4.9<sup>**</sup> | 56.11±5.78<sup>**</sup> | 0.345±0.035<sup>**</sup> |
实施例1组 | 10 | 34.6±6.2<sup>**</sup> | 46.81±6.88<sup>**</sup> | 0.395±0.045<sup>**</sup> |
实施例2组 | 10 | 32.8±5.8<sup>**</sup> | 47.51±5.86<sup>**</sup> | 0.385±0.041<sup>**</sup> |
实施例3组 | 10 | 33.7±5.4<sup>**</sup> | 47.25±5.34<sup>**</sup> | 0.390±0.047<sup>**</sup> |
对比例1组 | 10 | 25.9±4.9<sup>*</sup> | 67.49±10.55<sup>*</sup> | 0.229±0.044<sup>*</sup> |
对比例2组 | 10 | 26.2±4.7<sup>*</sup> | 69.33±8.87<sup>*</sup> | 0.252±0.059<sup>*</sup> |
对比例3组 | 10 | 23.9±4.0<sup>*</sup> | 62.32±9.05<sup>*</sup> | 0.223±0.042<sup>*</sup> |
注:与空白对照组比较,#P<0.05,##P<0.01;与模型组比较,*P<0.05,**P<0.01。
由上表3和表4结果可知:
(1)模型对照组小鼠给予复方地芬诺酯后,墨汁推进率、6小时内的粪便粒数和粪便重量明显减小,排便时间明显增加,与同期空白对照组相比,具有极显著性差异(P<0.01),说明便秘模型造模成功。
(2)本各实验组与模型对照组比较,均能不同程度地增加6小时小鼠排出的粪便重量和粪便粒数,排便时间明显减少,墨汁推进率明显升高,具有极显著性差异(P<0.01),说明各实验组都具有润肠通便的作用。
(3)本发明实施例1~3与阳性对照组相比,墨汁推进率、排便时间和粪便重量无明显差异,说明本发明所制备的香蕉冻干粉组合物具有与市售绿瘦纤姿饮青香蕉固体饮料同等的润肠通便效果。
(4)对比例1~3与实施例1相比,对比例1(酿酒酵母发酵)、对比例2(酿酒酵母发酵+SOD)和对比例3(无亚麻酸)的墨汁推进率、粪便粒数和粪便重量都不如实施例1大,排便时间也较长,润肠通便效果有所降低,其中对比例1与对比例2数据相差不大,说明SDO重组酵母发酵的作用不是将酿酒酵母与SOD简单混合使用就能替代的,而亚麻酸成分的省略也会对香蕉冻干粉组合物的通便效果产生不良的影响。
试验例三、降血糖、降脂试验
1.试验材料:实施例1和对比例1~3制备的香蕉冻干粉组合物。
2.试验对象:SPF级小鼠140只,雌雄各半,体重20±2g。
3.试验方法:
3.1造模与分组:
(1)糖尿病:小鼠适应性喂养1周后,随机10只分为空白组,60只作为实验组,于造模前禁食12小时,造模采用链脲佐菌素(STZ:上海阿拉丁生化科技股份有限公司)55mg/kg一次性腹腔注射,给药后24小时测血糖、尿糖,连续3天,尿糖定性+++以上,血糖值超过16.5mmol/L,并保持不变者,确定为造模成功,将造模成功的小鼠随机分为6组,模型组、阳性对照组(盐酸二甲双胍:上海阿拉丁生化科技股份有限公司)、实施例1组和对比例1~3组。
(2)高血脂:小鼠适应性喂养1周后,随机10只分为空白组,60只作为实验组,于造模前禁食12小时,以高脂乳剂(含1%胆固醇、20%猪油、2%胆酸钠和1%丙基硫嘧啶)喂养7天。将造模成功的小鼠随机分为模型组、阳性对照组(盐酸二甲双胍)、实施例1组和对比例1~3组。
3.2给药与测定:
正常对照组和模型对照组每天5ml蒸馏水,阳性对照组每天0.2g/kg盐酸二甲双胍,实施例1和对比例1~3每天5ml(0.03g/ml)相应制备的香蕉冻干粉组合物冲调的水溶液,每天1次,连续30天。末次给药前12小时禁食,给药后2小时,眶静脉取血,用全自动生化分析仪测定血糖和血脂。
4.试验结果:
香蕉冻干粉组合物对小鼠血糖、血脂的影响见表5和表6。
表5香蕉冻干粉组合物对小鼠血糖的影响
注:与空白对照组比较,#P<0.05,##P<0.01;与模型组比较,*P<0.05,**P<0.01。
表6香蕉冻干粉组合物对小鼠血脂的影响
注:与空白对照组比较,#P<0.05,##P<0.01;与模型组比较,*P<0.05,**P<0.01。
由表5和表6可知:
(1)本发明实施例1组与阳性对照组(盐酸二甲双胍)给药后血糖和血脂降低效果无明显差别,说明本发明的香蕉冻干粉组合物能够取得与盐酸二甲双胍同等的降血糖和血脂的作用。
(2)对比例1~3与实施例1相比,对比例1(酿酒酵母发酵)、对比例2(酿酒酵母发酵+SOD)和对比例3(无亚麻酸)给药后血糖和血脂降低效果明显不如实施例1好,其中对比例1和对比例2降糖和降脂效果相差不多但与实施例1却有显著的差异,说明重组SOD酵母发酵能显著提高香蕉冻干份组合物的降糖降脂效果,但这种效果是将酿酒酵母与SOD简单混合使用所无法达到的,而对比例3去掉亚麻酸会使香蕉冻干粉组合物的降糖降脂效果显著降低。
上述实施例仅例示性说明本发明的原理及其功效,而非用于限制本发明。任何熟悉此技术的人士皆可在不违背本发明的精神及范畴下,对上述实施例进行修饰或改变。因此,举凡所属技术领域中具有通常知识者在未脱离本发明所揭示的精神与技术思想下所完成的一切等效修饰或改变,仍应由本发明的权利要求所涵盖。
Claims (6)
1.一种具有通便功能的香蕉冻干粉组合物,其特征在于,包括如下原料及其重量份数:香蕉发酵冻干粉10~15份、菊粉1~4份、硬脂酸镁0.05~1.2份、乳化剂0.1~0.3份、亚麻酸0.5~1.5份和植物复合油0.4~1.6份;
所述香蕉发酵冻干粉的制备方法为:
S1、将青香蕉置于含0.05%乙烯的密闭环境中,控制环境温度为25~29℃,采用紫外光照射至香蕉果肉成熟;
S2、将步骤S1所得成熟的香蕉去皮、果肉挤压成浆后加入0.5wt%的异柠檬酸钠,搅拌均匀,35℃时加入1~3wt%的乳酸菌和3~5wt%的重组酵母,发酵3.5~4.5h,得香蕉发酵产物;
S3、向步骤S2所得香蕉发酵产物加入1~3wt%的精氨酸,充分混匀后放入封闭式氮气循环烤箱,设置温度80~90℃,烘干5~7h,得香蕉发酵果肉;
S4、将步骤S3所得香蕉发酵果肉在氮气环境,-18~-22℃条件下冻干后,超微粉碎,即得;
步骤S2中所述重组酵母为中国专利申请CN103333913A所公开的一种可以分泌表达超氧化物歧化酶的工程酿酒酵母。
2.根据权利要求1所述的具有通便功能的香蕉冻干粉组合物,其特征在于,包括如下原料及其重量份数:香蕉发酵冻干粉12.5份、菊粉2.5份、硬脂酸镁0.08份、乳化剂0.15份、亚麻酸1份和植物复合油1份。
3.根据权利要求1或2所述的具有通便功能的香蕉冻干粉组合物,其特征在于,所述植物复合油由亚麻籽油、杜仲籽油和紫苏籽油按体积比(1~3):(1~3):(1~3)组成。
4.根据权利要求1或2所述的具有通便功能的香蕉冻干粉组合物,其特征在于,所述乳化剂由胆固醇和磷脂按重量比(1~3):(8~12)组成。
5.根据权利要求4所述的具有通便功能的香蕉冻干粉组合物,其特征在于,所述乳化剂由胆固醇和磷脂按照1:10的重量比组成。
6.根据权利要求1~5任一项所述的具有通便功能的香蕉冻干粉组合物的制备方法,其特征在于,包括以下步骤:
A)将所述香蕉发酵冻干粉、菊粉和硬脂酸镁按相应的重量份数混合,超微粉碎,得粉末Ⅰ;
B)将亚麻酸和植物复合油按相应的重量份数混合均匀,得混合物Ⅱ;
C)将粉末Ⅰ、混合物Ⅱ和乳化剂混合均匀后喷雾干燥,粉碎,过筛,即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810050946.7A CN107981344B (zh) | 2018-01-18 | 2018-01-18 | 一种具有通便功能的香蕉冻干粉组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810050946.7A CN107981344B (zh) | 2018-01-18 | 2018-01-18 | 一种具有通便功能的香蕉冻干粉组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107981344A CN107981344A (zh) | 2018-05-04 |
CN107981344B true CN107981344B (zh) | 2021-04-06 |
Family
ID=62041153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810050946.7A Active CN107981344B (zh) | 2018-01-18 | 2018-01-18 | 一种具有通便功能的香蕉冻干粉组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107981344B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109363021A (zh) * | 2018-10-16 | 2019-02-22 | 宾川县华侨庄园农业科技开发有限公司 | 一种柑橘汁的加工方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102266057A (zh) * | 2011-08-22 | 2011-12-07 | 华南理工大学 | 具有润肠通便和减轻体重功能的香蕉粉的制作方法 |
CN102524639A (zh) * | 2011-12-15 | 2012-07-04 | 广东汤臣倍健生物科技股份有限公司 | 一种具有通便及保健功能的果蔬纤维咀嚼片及其制备方法 |
CN102599270A (zh) * | 2012-03-27 | 2012-07-25 | 河南大学 | 一种富含α-亚麻酸的保健调味油及其制备方法 |
CN104431945A (zh) * | 2014-12-08 | 2015-03-25 | 汕头市华馨香料有限公司 | 一种美拉德反应制备榴莲香精的方法 |
CN105079309A (zh) * | 2015-09-22 | 2015-11-25 | 青海文泰粮油科技有限公司 | 一种润肠通便的组合物 |
CN107114770A (zh) * | 2017-06-29 | 2017-09-01 | 张萌 | 提高水果酵素香气的制备方法 |
-
2018
- 2018-01-18 CN CN201810050946.7A patent/CN107981344B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102266057A (zh) * | 2011-08-22 | 2011-12-07 | 华南理工大学 | 具有润肠通便和减轻体重功能的香蕉粉的制作方法 |
CN102524639A (zh) * | 2011-12-15 | 2012-07-04 | 广东汤臣倍健生物科技股份有限公司 | 一种具有通便及保健功能的果蔬纤维咀嚼片及其制备方法 |
CN102599270A (zh) * | 2012-03-27 | 2012-07-25 | 河南大学 | 一种富含α-亚麻酸的保健调味油及其制备方法 |
CN104431945A (zh) * | 2014-12-08 | 2015-03-25 | 汕头市华馨香料有限公司 | 一种美拉德反应制备榴莲香精的方法 |
CN105079309A (zh) * | 2015-09-22 | 2015-11-25 | 青海文泰粮油科技有限公司 | 一种润肠通便的组合物 |
CN107114770A (zh) * | 2017-06-29 | 2017-09-01 | 张萌 | 提高水果酵素香气的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107981344A (zh) | 2018-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102379524B1 (ko) | 쌀 발효물을 유효성분으로 포함하는 장기능 또는 염증성 장질환 개선, 치료 또는 예방용 조성물 | |
CN102940014A (zh) | 一种紫薯燕麦保健月饼及馅料的制备方法 | |
KR101969809B1 (ko) | 천연 발효빵의 제조방법 및 이에 의해 제조된 천연 발효빵 | |
CN105875763A (zh) | 一种防便秘孕妇营养饼干 | |
WO2006132042A1 (ja) | 食薬栄養末と油脂 | |
KR100666054B1 (ko) | 구아바 식물성분을 함유한 찐빵 및 그 제조방법 | |
CN106665748A (zh) | 一种米饼的制备方法 | |
CN107981344B (zh) | 一种具有通便功能的香蕉冻干粉组合物及其制备方法 | |
CN106614905B (zh) | 一种幼儿营养米饼的制备方法 | |
KR20060084977A (ko) | 복분자를 함유한 양계 사료 조성물 및 이를 투여하여생산된 계란 | |
KR102017341B1 (ko) | 육돈용 사료 조성물 | |
KR20180075357A (ko) | 아로니아가 함유된 소스 조성물 | |
KR102498054B1 (ko) | 홍미를 이용한 기능성 피자 도우의 제조 방법 및 그 기능성 피자 도우 | |
CN115336749B (zh) | 一种富含ω-3多不饱和脂肪酸的亚麻籽组合物及其制备方法 | |
CN107149005B (zh) | 一种红茶菌戊聚糖奶片的制备方法 | |
KR101654705B1 (ko) | 발효 홍화씨 분말을 이용한 홍화차 제조방법 | |
CN104116070A (zh) | 一种具有保健作用的富硒有机绿茶养生酥饼及其制法 | |
KR101690416B1 (ko) | 천마, 미강, 치아씨, 녹차분말을 이용한 건강기능식품의 제조방법 | |
KR101660382B1 (ko) | 발효 홍화씨 분말을 이용한 홍화 음료 제조방법 | |
RU2305416C2 (ru) | Пищевая эмульсионная паста и способ ее получения | |
KR102610704B1 (ko) | 바질씨앗이 함유된 샤인머스켓청의 제조방법 | |
KR102651331B1 (ko) | 저열량 떡볶이떡 제조방법 | |
KR102527825B1 (ko) | 바게트용 연유크림의 제조방법 및 이에 의해 제조된 연유크림 | |
CN114431353B (zh) | 一种高蛋白低脂肪宠物食品及其制备方法 | |
CN108522970A (zh) | 一种海藻类原料制成的糖尿病全营养配方食品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |